glp 1 agonists and pancreatitis Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy Pancreatitis risk from GLP1 use
Description
Jastreboff et al., NEJM, 2023
Lets break it down
doi: 10.3389/fendo.2022.891297 127 ChangZPDengGFShaoYYXuDZhaoYNSunYFet al
Pooled estimates for hormonal parameters in PCOS women FAI: Thirteen studies (852 participants) were pooled for the analysis of post-interventional FAI values (Electronic Supplementary Fig
GLP-1 analogs and other drugs that target and activate GLP-1 receptors are collectively known as GLP-1 receptor agonists (GLP-1RAs)
Pedersen SD, Umpierrez GE, Giorgino F, Rodriguez A, Thieu V, Sapin H, Fenrandez Lando L, Karanikas CA, Kiljanski JI
